Sign in

CIK 0001781983 · Non-accelerated filer<br>Smaller reporting company

Aprea Therapeutics, Inc.

Sign in to watch
Ticker
APRE
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
Phone
215-948-4119
Business address
3805 OLD EASTON ROAD, DOYLESTOWN, PA, 18902
  1. 3 Insider Initial Statement of Ownership
  2. 3 Insider Initial Statement of Ownership
  3. 3 Insider Initial Statement of Ownership
  4. 3 Insider Initial Statement of Ownership
  5. 4 Open-market buy Director bought 50,000 shares at $0.71 ($35,500)
  6. 4 Open-market buy Chairman & CEO bought 37,500 shares at $0.64 ($24,124)
  7. 4 Grant or award Chairman & CEO acquired 100,100 shares (grant or award)
  8. 4 Shares withheld for taxes SVP, Chief Business Officer gave up 1,989 shares (to pay taxes)
  9. 4 Grant or award SVP, Chief Financial Officer acquired 42,900 shares (grant or award)
  10. 4 Grant or award SVP, Chief Medical Officer acquired 42,900 shares (grant or award)
  11. 4 Grant or award SVP, Chief Scientific Officer acquired 24,700 shares (grant or award)
  12. 4 Shares withheld for taxes Chairman & CEO gave up 21,644 shares (to pay taxes)
  13. 4 Shares withheld for taxes SVP, Chief Business Officer gave up 1,326 shares (to pay taxes)
  14. 4 Shares withheld for taxes SVP, Chief Financial Officer gave up 14,817 shares (to pay taxes)
  15. 4 Open-market sale SVP, Chief Medical Officer sold 36,000 shares at $1.73 ($62,280)
  16. 4 Open-market sale SVP, Chief Business Officer sold 27,500 shares at $3.96 ($108,900)
  17. 4 Open-market sale SVP, Chief Business Officer sold 27,500 shares at $5.00 ($137,500)
  18. 4 Open-market sale SVP, Chief Scientific Officer sold 50,000 shares at $4.89 ($244,500)
  19. 4 Open-market sale SVP, Chief Business Officer sold 27,500 shares at $4.89 ($134,475)
  20. 4 Open-market sale SVP, Chief Business Officer sold 32,960 shares at an average $4.97 ($163,866)

Page 5 of 9 · 180 filings